SSRI Documents

Baum Hedlund’s SSRI Documents

PDF References

Testimony before the Psychopharmacologic Drugs Advisory Committee (PDAC)

Results of FDA’s Ongoing Meta-analysis of Suicidality Data from Adult Antidepressant Trials

December 13, 2006

Baum Hedlund Law Firm

Prozac Timeline

May 25, 1984

Internal memorandum from Eli Lilly and Company [ pdf 01]

June 26, 1984

BGA (German equivalent of FDA) Report [ pdf 02]

January 29, 1985

BGA (German equivalent of FDA) Report [pdf 03]

February 26, 1985

BGA (German equivalent of FDA) Report [ pdf 04]

April 1, 1986

BGA (German equivalent of FDA) Memorandum [ pdf 05]

August 30, 1989

BGA Consultant Group Feedback [ pdf 06]

March 23, 1985

FDA Safety Review of Prozac [ pdf 07]

March 23, 1985

FDA Safety Review of Prozac [ pdf 08]

March 23, 1985

FDA Safety Review of Prozac [ pdf 09]

February, 1990

Harvard Study:

Emergence of Intense Suicidal Preoccupation During Fluoxetine [Prozac] Treatment [ pdf 10]

November 16, 1994

Testimony of Lilly Representative, Dr. Gary Tollefson [ pdf 11]

October 3, 1990

FDA Memorandum [ pdf 12]

September 20, 1991

FDA Psychopharmacological Drugs Advisory Committee [ pdf 13]

Our Awards

  • Best Law Firms 2021
  • National Trial Lawyers Top 100
  • Elite Trial Lawyers
  • AV Top Ranked Law Firm
  • Listed in Best Lawyers
  • Verdicts Hall of Fame
  • AV Rated
  • Super Lawyers
  • National Board of Trial Advocacy
  • Lawdragon 500 Leading Plaintiff Consumer Lawyers
  • Multi-Million Dollar Advocates Forum
  • Bar Register of Preeminent Lawyers

Biffle vs. Eli Lilly

Defendants Amend and Supplemental Answers to Plaintiffs’ First Interrogatories [ pdf 14]

June 3, 1992

Letter from FDA to Public Citizen [ pdf 15]

January 20, 1994

Pfizer Memorandum [ pdf 16] Obtained in Litigation

Written by Pfizer’s top scientist at the time

September 11, 1990

FDA Memorandum [ pdf 17]

Obtained through the Freedom of Information Act

Dr. David Graham

November 23, 2006

New England Journal of Medicine:

Dangerous Deception — Hiding the Evidence of Adverse Drug Effects [ pdf 18]

Jeffrey Avorn, MD

October 14, 2004

New England Journal of Medicine:

A Black Box Warning for Antidepressants in Children? [ pdf 20]

Thomas B. Newman, MD, MPH

September 23, 2004

Hearing: House of Representatives Committee on Energy and Commerce

Oversight and Investigations Subcommittee [ pdf 21]

108th Congress

February 2, 2004

FDA Psychopharmacological Drugs Advisory Committee [ pdf 22]

May, 2006

GSK Important Prescribing Information [ pdf 23]

July 15, 2002

American Psychological Association:

Antidepressants and Placebos: Secrets, Revelations and Unanswered Questions [ pdf 24]

Irving Kirsch, Alan Scoboria and Thomas J. Moore

July 15, 2005

British Medical Journal:

Efficacy of Antidepressants in Adults [ pdf 25]

Joanna Moncrieff and Irving Kirsch

December 24, 1991

FDA Memorandum [ pdf 26]

Firm Reviews

What Our Clients Are Saying
  • Top Legal Minds in the Country

    “The Baum, Hedlund firm has some of the top legal minds in the country; they are driven, determined, trustworthy, ethical and passionate.”

    - From Best Lawyers® Best Law Firms
  • I Can’t Imagine a Better Law Firm

    “Multiple lawyers recommended Baum Hedlund to me and I have been consistently impressed with the quality of their work.”

    - Best Law Firms Survey
  • Diligent & Professional Representation

    “Thanks to your efforts I was able to recover from a tragic experience and turn my life around for the best.”

    - W.T.
  • Our Best Interest Was Always Number One on Your List

    “A special thank you to your Spanish-speaking staff for the extra effort put into this case. The language barrier was never a problem, and we are so very thankful to them. Your name holds much respect in our family.”

    - G.C. & C.C
  • We Have Never Met a More Wonderful Group of People

    “It is obvious that the people at Baum, Hedlund, Aristei, & Goldman believe in what they do. And that you all really care about your clients.”

    - The B. Family

Contact Us Today

No Fees Unless We Win
  • Please enter your first name.
  • Please enter your last name.
  • +1
    Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please enter your city.
  • Please make a selection.
  • Please make a selection.
  • Please enter a message.